It was found that Ciprofloxacin Kabi cartons contained bottles labeled Glucosum 5% Fresenius with the same batch number, indicating mix-up of infusion products and risk of administering the wrong medicine. Potential effects: lack of efficacy, infusion-related complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 15QFD570; healthcare facilities and pharmacies should immediately segregate this batch and return it to the wholesaler or the marketing authorisation holder.
Withdrawal from the market throughout the country of batch 15QFD570 of the medicinal product Ciprofloxacin Kabi 400 mg/200 ml solution for infusion, granting the decision immediate enforceability, and...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related